UğuzEKurtulAŞenF. Effect of carvedilol versus metoprolol on contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous intervention therapy. Angiology. 2024;75:323-30.
2.
ÖzdemirEAkçayFAEsenS, et al.Predictive value of the modified mehran score for contrast-induced nephropathy after transcatheter aortic valve implantation. Angiology. 2024;75:267-73.
3.
UlusTIsgandarovKYilmazAS, et al.Monocyte to high-density lipoprotein ratio predicts contrast-induced nephropathy in patients with acute coronary syndrome. Angiology. 2018;69:909-16.
4.
McCulloughPA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-28.
5.
KelesogluSYilmazYElcıkD, et al.Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-ST segment elevation myocardial infarction. Angiology. 2021;72:889-95.
6.
BağcıAAksoyFBaşHA. Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2022;73:218-24.
7.
CetinkayaZKelesogluS. The role of pan-immune-inflammation value in predicting contrast-induced nephropathy development in patients undergoing percutaneous coronary intervention due to NSTEMI. Angiology. 2025;76:281-8.
8.
ByrneRARosselloXCoughlanJESC Scientific Document Group, et al.. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J Acute Cardiovasc Care. 2024;13:55-161.
9.
YueTLChengH-YLyskoPG, et al.Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Therapeut. 1992;263:92-8.
10.
YuanZShiojiKKiharaYTakenakaHOnozawaYKishimotoC. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol. 2004;286:H83–H90.
11.
WuZZhangHJinW, et al.The effect of renin-angiotensin-aldosterone system blockade medications on contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis. PLoS One. 2015;10:e0129747.